Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications
DNA damage repair (DDR) pathways play an essential role in maintaining genomic integrity. DDR dysfunction leads to accumulated DNA damage, predisposition to cancer, and high sensitivity to chemotherapy and radiotherapy. Recent studies have demonstrated that DDR status is associated with response to...
Main Authors: | Wei Sun, Qing Zhang, Runkun Wang, Yang Li, Yue Sun, Lin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.648687/full |
Similar Items
-
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
by: Yawen Dong, et al.
Published: (2021-04-01) -
DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors
by: Yipeng Song, et al.
Published: (2021-02-01) -
Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade
by: Min Hwa Shin, et al.
Published: (2020-04-01) -
Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
by: Jingjing Duan, et al.
Published: (2018-09-01) -
Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer
by: Hanfei GUO, et al.
Published: (2020-02-01)